About Bausch Health
Bausch Health is a company based in Laval (Canada) founded in 1960.. The company has 20,700 employees as of December 31, 2024. Bausch Health has completed 19 acquisitions, including Aton Pharma, Bausch & Lomb and DURECT. Bausch Health offers products and services including Gastrointestinal Products, Dermatology Products, and Vision Care Products. Bausch Health operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.
- Headquarter Laval, Canada
- Employees 20700 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bausch Health Companies Inc.
-
Annual Revenue
$9.17 B (USD)11.56as on Dec 31, 2024
-
Net Profit
$-43.8 M (USD)92.11as on Dec 31, 2024
-
EBITDA
$2.97 B (USD)10.61as on Dec 31, 2024
-
Latest Funding Round
$500 M (USD), Debt – Conventional
Mar 08, 2019
- Investors
-
Employee Count
20700
as on Dec 31, 2024
-
Investments & Acquisitions
Aton Pharma
& 18 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bausch Health
Bausch Health is a publicly listed company on the TSX with ticker symbol BHC in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bausch Health
Bausch Health offers a comprehensive portfolio of products and services, including Gastrointestinal Products, Dermatology Products, and Vision Care Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats gastrointestinal disorders with innovative medications.
Provides solutions for skin conditions and aesthetic treatments.
Offers eye care solutions including devices and pharmaceuticals.
Unlock access to complete
Software Development Team
152 people
Leadership Team
84 people
Sales and Marketing
62 people
Finance and Accounting
42 people
Senior Team
28 people
Legal and Compliance
24 people
Human Resources and Administration
17 people
Operations Team
17 people
Unlock access to complete
Funding Insights of Bausch Health
- Total Funding Total Funding
- Total Rounds 11
- Last Round Debt – Conventional — $500.0M
-
First Round
First Round
(26 Mar 2002)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2019 | Amount | Debt – Conventional - Bausch Health | Valuation |
investors |
|
| Nov, 2018 | Amount | Debt – Conventional - Bausch Health | Valuation |
investors |
|
| Jun, 2018 | Amount | Debt – Conventional - Bausch Health | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bausch Health
Bausch Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ValueAct Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm based out of USA
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bausch Health
Bausch Health has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Aton Pharma, Bausch & Lomb and DURECT. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of an augmented reality marketing platform
|
2015 | ||||
|
Drugs for hypoactive sexual desire disorder in women are developed.
|
2011 | ||||
|
Pharmaceuticals and food supplements are manufactured and distributed.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bausch Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bausch Health Comparisons
Competitors of Bausch Health
Bausch Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bausch Health
Frequently Asked Questions about Bausch Health
When was Bausch Health founded?
Bausch Health was founded in 1960 and raised its 1st funding round 42 years after it was founded.
Where is Bausch Health located?
Bausch Health is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Who is the current CEO of Bausch Health?
Joseph Papa is the current CEO of Bausch Health.
How many employees does Bausch Health have?
As of Dec 31, 2024, the latest employee count at Bausch Health is 20,700.
What is the annual revenue of Bausch Health?
Annual revenue of Bausch Health is $9.17B as on Dec 31, 2024.
What does Bausch Health do?
Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.
Who are the top competitors of Bausch Health?
Bausch Health's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
What products or services does Bausch Health offer?
Bausch Health offers Gastrointestinal Products, Dermatology Products, and Vision Care Products.
Is Bausch Health publicly traded?
Yes, Bausch Health is publicly traded on TSX under the ticker symbol BHC.
How many acquisitions has Bausch Health made?
Bausch Health has made 19 acquisitions, including Aton Pharma, Bausch & Lomb, and DURECT.
Who are Bausch Health's investors?
Bausch Health has 1 investor. Key investors include ValueAct Capital.
What is Bausch Health's ticker symbol?
The ticker symbol of Bausch Health is BHC on TSX.